Panelist: Fiona Mack
Currently, Fiona Mack is Head of East North America, External Scientific Innovation at Johnson and Johnson. In this role she is responsible for regional management of East North America and the team’s partnership portfolio sourcing through identification, incubation, and due diligence providing expert guidance on business strategy, sourcing, stakeholder management and governance. In addition, she serves as a global partner for Neuroscience to drive its external innovation strategy. Prior to joining Johnson and Johnson, Fiona was head of Bayer Co.Lab Cambridge, where she was responsible for launching and operationalizing Bayer’s life science incubator designed to support early-stage entrepreneurs with innovations in oncology, cardiovascular disease, immunology, and cell and gene therapy.
Fiona has held senior leadership positions at Ipsen, Roche and Pfizer supporting external innovation efforts to expand Rare Disease, Neuroscience and Oncology portfolios. Fiona earned her Ph.D. in Cell and Molecular Biology from the University of Pennsylvania and her undergraduate degree in Biology from Cornell University. Her innovative work has been published in high impact journals and she also has several granted patents.